Rafferty Asset Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.7M | Buy |
300,951
+47,626
| +19% | +$427K | 0.01% | 537 |
|
|
2025
Q1 | $1.9M | Buy |
253,325
+18,489
| +8% | +$139K | 0.01% | 592 |
|
|
2024
Q4 | $1.77M | Sell |
234,836
-136,198
| -37% | -$1.02M | 0.01% | 676 |
|
|
2024
Q3 | $2.82M | Sell |
371,034
-94,697
| -20% | -$720K | 0.01% | 552 |
|
|
2024
Q2 | $2.88M | Sell |
465,731
-1,104,051
| -70% | -$6.82M | 0.01% | 539 |
|
|
2024
Q1 | $7.97M | Buy |
1,569,782
+614,195
| +64% | +$3.12M | 0.03% | 347 |
|
|
2023
Q4 | $5.72M | Buy |
955,587
+147,699
| +18% | +$885K | 0.02% | 420 |
|
|
2023
Q3 | $5.72M | Sell |
807,888
-167,075
| -17% | -$1.18M | 0.03% | 361 |
|
|
2023
Q2 | $6.86M | Buy |
974,963
+154,442
| +19% | +$1.09M | 0.04% | 348 |
|
|
2023
Q1 | $6.84M | Buy |
820,521
+52,448
| +7% | +$437K | 0.05% | 299 |
|
|
2022
Q4 | $8.82M | Buy |
768,073
+252,845
| +49% | +$2.9M | 0.07% | 219 |
|
|
2022
Q3 | $6.49M | Buy |
515,228
+127,901
| +33% | +$1.61M | 0.07% | 251 |
|
|
2022
Q2 | $4.1M | Buy |
387,327
+55,614
| +17% | +$588K | 0.04% | 318 |
|
|
2022
Q1 | $5.39M | Sell |
331,713
-120,924
| -27% | -$1.97M | 0.03% | 373 |
|
|
2021
Q4 | $6.27M | Buy |
452,637
+247,639
| +121% | +$3.43M | 0.03% | 290 |
|
|
2021
Q3 | $2.95M | Buy |
204,998
+48,891
| +31% | +$703K | 0.02% | 486 |
|
|
2021
Q2 | $2.47M | Sell |
156,107
-107,477
| -41% | -$1.7M | 0.02% | 611 |
|
|
2021
Q1 | $2.68M | Buy |
263,584
+151,233
| +135% | +$1.54M | 0.02% | 550 |
|
|
2020
Q4 | $837K | Sell |
112,351
-413,951
| -79% | -$3.08M | 0.01% | 555 |
|
|
2020
Q3 | $1.81M | Buy |
526,302
+303,685
| +136% | +$1.04M | 0.02% | 449 |
|
|
2020
Q2 | $1.06M | Buy |
222,617
+205,417
| +1,194% | +$979K | 0.01% | 528 |
|
|
2020
Q1 | $34K | Sell |
17,200
-128,884
| -88% | -$255K | ﹤0.01% | 584 |
|
|
2019
Q4 | $504K | Sell |
146,084
-125,292
| -46% | -$432K | 0.01% | 687 |
|
|
2019
Q3 | $777K | Sell |
271,376
-109,118
| -29% | -$312K | 0.01% | 592 |
|
|
2019
Q2 | $1.44M | Buy |
380,494
+275,454
| +262% | +$1.04M | 0.03% | 496 |
|
|
2019
Q1 | $855K | Buy |
+105,040
| New | +$855K | 0.01% | 580 |
|